CA1251401A - Method for preparation of herpes simplex virus subunit vaccine - Google Patents

Method for preparation of herpes simplex virus subunit vaccine

Info

Publication number
CA1251401A
CA1251401A CA000489367A CA489367A CA1251401A CA 1251401 A CA1251401 A CA 1251401A CA 000489367 A CA000489367 A CA 000489367A CA 489367 A CA489367 A CA 489367A CA 1251401 A CA1251401 A CA 1251401A
Authority
CA
Canada
Prior art keywords
sulfuric acid
glycoproteins
acid ester
cellulose
crosslinked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000489367A
Other languages
English (en)
French (fr)
Inventor
Youichiro Kino
Tetsuo Kawahara
Hiroshi Mizokami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of CA1251401A publication Critical patent/CA1251401A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000489367A 1984-08-24 1985-08-23 Method for preparation of herpes simplex virus subunit vaccine Expired CA1251401A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP177194/1984 1984-08-24
JP59177194A JPS6153226A (ja) 1984-08-24 1984-08-24 単純ヘルペスサブユニツトワクチンの精製方法

Publications (1)

Publication Number Publication Date
CA1251401A true CA1251401A (en) 1989-03-21

Family

ID=16026819

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000489367A Expired CA1251401A (en) 1984-08-24 1985-08-23 Method for preparation of herpes simplex virus subunit vaccine

Country Status (7)

Country Link
US (1) US4724146A (https=)
EP (1) EP0173268B1 (https=)
JP (1) JPS6153226A (https=)
KR (1) KR920009735B1 (https=)
AT (1) ATE54415T1 (https=)
CA (1) CA1251401A (https=)
DE (1) DE3578617D1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
US5585264A (en) * 1988-07-15 1996-12-17 University Of Saskatchewan Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
US5447859A (en) * 1993-07-16 1995-09-05 Viagene Method for the purification or removal of retroviruses using sulfated cellulose
AU2002302069B2 (en) * 1998-03-05 2007-11-15 Cantab Pharmaceuticals Research Limited Virus preparations and methods
GB9804632D0 (en) * 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
US6342384B1 (en) * 1998-08-21 2002-01-29 The University Of Va Patent Foundation Production of adenoviral vectors using serum-free suspension cell culture in a hollow fiber system
EP2281573A3 (en) * 2001-02-23 2011-12-07 GlaxoSmithKline Biologicals s.a. Influenza vaccine formulations for intradermal delivery
CA2438960A1 (en) * 2001-02-23 2002-09-06 Glaxosmithkline Biologicals S.A. Influenza vaccine formulations for intradermal delivery
GB2386072A (en) * 2001-04-27 2003-09-10 Becton Dickinson Co Novel vaccine
US20070236809A1 (en) 2006-04-05 2007-10-11 Barret Lippey Forming spectral filters
US7959295B2 (en) 2007-05-18 2011-06-14 Dolby Laboratories Licensing Corporation Spectral separation filters for 3D stereoscopic D-cinema presentation
TWI402606B (zh) 2007-05-09 2013-07-21 Dolby Lab Licensing Corp 三維影像之投影與觀看系統
US7784938B2 (en) 2007-05-09 2010-08-31 Dolby Laboratories Licensing Corporation Method and system for shaped glasses and viewing 3D images
DE102013017014B4 (de) 2013-10-14 2017-03-30 Sartorius Stedim Biotech Gmbh Sulfatierte Cellulosehydrat-Membran, Verfahren zur ihrer Herstellung und Verwendung der Membran als Adsorptionsmembran für die Virenaufreinigung
US10809543B2 (en) 2017-01-23 2020-10-20 Dolby Laboratories Licensing Corporation Glasses for spectral and 3D imaging
CN111896731B (zh) * 2020-06-24 2023-06-09 宁波瑞源生物科技有限公司 一种化学发光免疫分析用清洗液

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4317811A (en) * 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
US4762708A (en) * 1982-02-18 1988-08-09 University Patents, Inc. Materials and methods for herpes simplex virus vaccination
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen

Also Published As

Publication number Publication date
US4724146A (en) 1988-02-09
KR870001837A (ko) 1987-03-28
EP0173268A3 (en) 1986-05-28
EP0173268B1 (en) 1990-07-11
DE3578617D1 (de) 1990-08-16
EP0173268A2 (en) 1986-03-05
JPH0463863B2 (https=) 1992-10-13
KR920009735B1 (ko) 1992-10-22
JPS6153226A (ja) 1986-03-17
ATE54415T1 (de) 1990-07-15

Similar Documents

Publication Publication Date Title
CA1251401A (en) Method for preparation of herpes simplex virus subunit vaccine
Haddad et al. Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells
Luka et al. Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines
CA1244766A (en) Herpes simplex virus subunit vaccine
Cohen et al. Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody
Hierholzer Purification and biophysical properties of human coronavirus 229E
AU594400B2 (en) Major iron-regulated protein of neisseria gonorrhoeae and its use as vaccine
EP0118885B1 (en) Method for purification of hepatitis b virus surface antigen
US4725547A (en) Method for purfication of rabic virus
EP0171765B1 (en) A method for purification of japanese encephalitis virus
US4666713A (en) Relating to hepatitis B vaccine
EP0112506B1 (en) A process for producing a hepatitis b infection preventing vaccine
CA1066190A (en) Vaccine for active immunization containing hepatitis b surface antigen and associated antigen
Wyn-Jones et al. Induction of virus-neutralizing antibody by glycoproteins isolated from chicken cells infected with a herpesvirus of turkeys
Stolzenberg et al. Purification and properties of Epstein-Barr virus DNase expressed in Escherichia coli
Onuma et al. Properties of the common antigen associated with Marek's disease herpesvirus and turkey herpesvirus infections
Spelsberg et al. Evidence for two classes of chromatin-associated Epstein-Barr virus-determined nuclear antigen
Buchmeier et al. Antigens of Pichinde virus I. Relationship of soluble antigens derived from infected BHK-21 cells to the structural components of the virion
Anthony et al. Studies of Variola Virus and immunity in smallpox: I. Variola Virus hemagglutinins
CA1256042A (en) Process for the purification of hbsag
Young et al. Preparation of hepatitis B polypeptide micelles from human carrier plasma
US5041536A (en) Pseudorabies virus (PRV) gene
Gschwender et al. Antigenic properties of the LCM virus: virion and complement-fixing antigen
Nath et al. Purification of Hepatitis B Surface Antigen Using Polyethylene Glycol, Pepsin and Tween 80 1
Aasletad et al. Recovery of protective activity in rabies virus vaccines concentrated and purified by four different methods

Legal Events

Date Code Title Description
MKEX Expiry